124 related articles for article (PubMed ID: 9605761)
1. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
Hansen LL; Yilmaz M; Overgaard J; Andersen J; Kruse TA
Cancer Res; 1998 May; 58(10):2166-9. PubMed ID: 9605761
[TBL] [Abstract][Full Text] [Related]
2. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
4. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract][Full Text] [Related]
5. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
[TBL] [Abstract][Full Text] [Related]
6. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of loss of heterozygosity in breast cancer].
Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
[TBL] [Abstract][Full Text] [Related]
8. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
[TBL] [Abstract][Full Text] [Related]
10. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal component.
Gaki V; Tsopanomichalou M; Sourvinos G; Tsiftsis D; Spandidos DA
Eur J Surg Oncol; 2000 Aug; 26(5):455-60. PubMed ID: 11016465
[TBL] [Abstract][Full Text] [Related]
12. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.
Smeds J; Wärnberg F; Norberg T; Nordgren H; Holmberg L; Bergh J
Acta Oncol; 2005; 44(1):41-9. PubMed ID: 15848905
[TBL] [Abstract][Full Text] [Related]
14. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
15. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
16. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
[TBL] [Abstract][Full Text] [Related]
17. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S
Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q.
Tsuda H; Hirohashi S
Cancer Res; 1995 Aug; 55(15):3395-8. PubMed ID: 7614478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
